Znn3bq.jpeg
²é¿´: 1520  |  »Ø¸´: 2

liuchongyu

Í­³æ (СÓÐÃûÆø)

[½»Á÷] »ÔÈðÖйúÕÐÆ¸ÇøÓòҽѧ¹ËÎÊ

¾ßÌ幤×÷µØµã:
ÉϺ£
н½ð:
ÃæÌ¸

¼òÀú·¢ËÍÖÁ£ºpfizerhr@sina.cn
ְλÃû³Æ£ºÇøÓòҽѧ¹ËÎÊ/Regional Medical Advisor
¹¤×÷µØµã£ºÉϺ£/Shanghai

Ö°ÔðResponsibilities
Maximize the value of Pfizer products to Chinese patients and health care professional within Pfizer¡¯s vision and mission. Develop KOLs management strategy and action plan. Establish the channel with China academic organization in the field to communicate Pfizer products medical information to key influencers and stakeholders. Implement medical programs and activities of inline products and pipeline in the fields. Provide professional medical training to commercial teams.

񻂗Qualifications
•Technical
Therapeutic area knowledge: familiar with the disease knowledge and clinical practice of the therapeutic area
Language: Proficiency in oral and written English
Good understanding about pharmaceutical business
Computer: Good at Microsoft Office software
Strong business acumen
Cross functional leadership skill
Strong communication and influencing skill
•Managerial
Sustain Focus on Performance
Create an Inclusive Environment
Encourage Open Discussion and Debate
Manage Change
Develop People
Align Across Pfizer
•Education
Medical Background, Master Degree or above in the defined therapeutic area is preferred
•Experience
At least 2 years clinical practice experience in defined area with good medical knowledge
Good understanding about pharmaceutical business, Medical affairs experience or clinical studies experience in multinational pharmaceutical companies is preferred
Proficiency in English and good computer usage

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rethink

ľ³æ (ÕýʽдÊÖ)

Ò©Àíѧ²©Ê¿£¬Ã÷Äê±ÏÒµ£¬Óлú»áÂð£¿ÊµÏ°Ò²¿ÉÒÔµÄ
2Â¥2012-09-25 21:42:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

rockliu

Í­³æ (СÓÐÃûÆø)

ÄúºÃ£¬¹¤×÷1Ä꣬ÄÜ·ñ¸ø¸ö»ú»áÃæÊÔ£¿£¿£¿
ÎÒÏëÎÒÊǺ£
3Â¥2012-09-25 21:58:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ liuchongyu µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 300Çóµ÷¼Á +12 ³Èa777 2026-04-15 12/600 2026-04-18 23:51 by ·²¡Çé
[¿¼ÑÐ] 320Çóµ÷¼Á +5 Éî½¼akm 2026-04-17 5/250 2026-04-18 19:52 by Íõ¬Bè±
[¿¼ÑÐ] ½ÓÊÜÈκε÷¼Á +6 Ò²¾ÍÊÇÀõ×Ó 2026-04-17 7/350 2026-04-18 17:20 by º­ÖñÁõ
[¿¼ÑÐ] ÊÕµ½¸´ÊÔµ÷¼Áµ«ÊÇÈ¥²»ÁË +8 СÎÏÅ£* 2026-04-16 8/400 2026-04-18 11:15 by zixin2025
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô +33 yzyzx 2026-04-12 37/1850 2026-04-17 23:00 by wunaiy88
[Óлú½»Á÷] ¶þ±½¼×ͪËáÀàÑÜÉúÎï 50+3 С°×°®Ö÷ÈË 2026-04-17 6/300 2026-04-17 18:47 by kf2781974
[ÂÛÎÄͶ¸å] ÓÐûÓнÓÊձȽϿìµÄsciÆÚ¿¯Ñ½£¬×îºÃÔÚÒ»¸öÔÂÖ®Äڵģ¬ÑÐÈýº¢×ÓÇó±ÏÒµ 20+4 Ö®»¤×Å 2026-04-16 5/250 2026-04-17 10:02 by bobvan
[¿¼ÑÐ] 294Çóµ÷¼Á +14 µ­È»654321 2026-04-15 14/700 2026-04-16 21:01 by lpl364211
[¿¼ÑÐ] 291Çóµ÷¼Á +11 ¹ØÒä±±. 2026-04-14 11/550 2026-04-16 15:18 by jiahl2024
[»ù½ðÉêÇë] RY£ºÖйú²ú³öµÄ¿ÆÑ§À¬»øÂÛÎÄ£¬¾ø¶ÔÊýÁ¿ºÍ±ÈÀý¶¼ÊÀ½çµÚÒ» +7 zju2000 2026-04-14 18/900 2026-04-16 11:36 by »¶ÀÖËÌÒ¶Ýè
[¿¼ÑÐ] Çóµ÷¼ÁѧУ +14 ²»»á³ÔÈâ 2026-04-13 16/800 2026-04-15 21:59 by noqvsozv
[¿¼ÑÐ] ͨÐŹ¤³ÌÇóµ÷¼Á£¡£¡£¡ +6 zlb770521 2026-04-14 6/300 2026-04-15 20:00 by ѧԱJpLReM
[¿¼ÑÐ] 085801µçÆø×¨Ë¶272Çóµ÷¼Á +19 µçÆøÀî 2026-04-13 21/1050 2026-04-15 13:37 by ºÚ¿Æ¼¼¿óÒµ
[¿¼ÑÐ] 297¹¤¿Æµ÷¼Á? +14 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-13 15/750 2026-04-15 13:25 by ºÚ¿Æ¼¼¿óÒµ
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤349·ÖÇóµ÷¼Á +16 Àîľ×Ó°¡¹þ¹þ 2026-04-12 17/850 2026-04-14 09:11 by fenglj492
[¿¼ÑÐ] ¿¼ÑÐÓ¢Ò»ÊýÒ»338·Ö +9 ³¤½­´óѧ¶«Ð£Çø 2026-04-13 10/500 2026-04-14 00:41 by Íõ¬Bè±
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] 302Çóµ÷¼Á +10 Ò×£¡? 2026-04-13 10/500 2026-04-13 19:04 by lbsjt
[¿¼ÑÐ] 297¹¤¿Æ£¬Çóµ÷¼Á? +13 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-12 13/650 2026-04-13 14:12 by dingyanbo1
[¿¼ÑÐ] 339Çóµ÷¼Á +4 hanwudada 2026-04-12 4/200 2026-04-13 12:03 by À¶ÔÆË¼Óê
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û